COSMO Pharmaceuticals SA (COPN) — Long-term Investment Intensity
COSMO Pharmaceuticals SA (COPN) has a Long-term Investment Intensity of 24.3% as of June 2019. Long-term investments of CHF144.35 Million represent 24.3% of total assets of CHF594.73 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check COPN cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
LT Investment Intensity
Long-term Investments
Total Assets
Country
COSMO Pharmaceuticals SA Long-term Investment Intensity (2013–2018)
This chart shows how COSMO Pharmaceuticals SA's Long-term Investment Intensity has evolved across 6 annual periods from 2013 to 2018. As of June 2019, the intensity stands at 24.3%, reflecting long-term investments of CHF144.35 Million against total assets of CHF594.73 Million CHF. Explore how well can COSMO Pharmaceuticals SA service its debt to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for COSMO Pharmaceuticals SA (2013–2018)
The table below presents the year-by-year Long-term Investment Intensity for COSMO Pharmaceuticals SA from 2013 to 2018, covering 6 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see COSMO Pharmaceuticals SA market cap and net worth.
| Year | LT Investment Intensity | LT Investments (CHF) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2018 | 27.5% | CHF172.26 Million | CHF625.69 Million | ▼ -18.6 pp |
| 2017 | 46.1% | CHF229.55 Million | CHF497.97 Million | ▼ -2.0 pp |
| 2016 | 48.1% | CHF213.50 Million | CHF443.47 Million | ▼ -14.0 pp |
| 2015 | 62.2% | CHF272.22 Million | CHF437.94 Million | ▲ +8.6 pp |
| 2014 | 53.6% | CHF120.83 Million | CHF225.62 Million | ▲ +47.0 pp |
| 2013 | 6.6% | CHF16.00 Million | CHF243.00 Million | — |